Revance Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

21.06.18	Revance Doses First Patient in ASPEN Phase 3 Clinical Program of RT002 Injectable for the Treatment of Cervical Dystonia (Businesswire)
14.06.18	Revance to Participate in the JMP Securities Life Sciences Conference 2018 (Businesswire)
05.06.18	Revance to Participate in Upcoming Investor Conferences (Businesswire)
29.05.18	Revance to Participate in the Jefferies 2018 Global Healthcare Conference (Businesswire)
29.05.18	Revance Announces Departure of Chief Financial Officer (Businesswire)
24.05.18	Revance Announces Publication of Positive 24-Week Duration of Effect Results from Cervical Dystonia Phase 2 Trial in Movement Disorders Clinical Practice (Businesswire)
15.05.18	Revance to Participate in the UBS Global Healthcare Conference (Businesswire)
09.05.18	Revance Therapeutics Announces Two Recent Additions to Its Management Team (Businesswire)
08.05.18	Revance Releases First Quarter 2018 Results (Businesswire)
01.05.18	Revance Therapeutics Expands Leadership Team, Appointing Caryn McDowell as SVP, General Counsel & Corporate Secretary (Businesswire)
25.04.18	Pivotal SAKURA Phase 3 Clinical Data to be Featured in Oral and Poster Presentations at The Aesthetic Meeting 2018 (Businesswire)
24.04.18	Revance Therapeutics to Release First Quarter 2018 Financial Results on Tuesday, May 8, 2018 (Businesswire)
19.04.18	Revance Investor Day Highlights New Neuroscience Indications in Development (Businesswire)
02.04.18	Revance Therapeutics Expands Commercialization Team to Gear Up for Product Launch of RT002 Injectable (Businesswire)
26.03.18	Revance to Host Investor Day on April 19, 2018 (Businesswire)
20.03.18	Revance to Participate in the Needham Healthcare Conference (Businesswire)
06.03.18	Revance to Participate in Upcoming Investor Conferences (Businesswire)
28.02.18	Mylan, Revance Announce License Agreement For Proposed Biosimilar To BOTOX (RTTNews)
28.02.18	Revance Releases Fourth Quarter and Full Year 2017 Results (Businesswire)
28.02.18	Mylan to Bring a Biosimilar of BOTOX to the Market Through a Collaboration and License agreement with Revance Therapeutics (PR Newswire)
22.02.18	Revance Therapeutics to Release Fourth Quarter and Full Year 2017 Financial Results on Wednesday, February 28, 2018 (Businesswire)
14.02.18	Revance to Participate in the RBC Capital Markets 2018 Global Healthcare Conference (Businesswire)
08.01.18	Revance Announces Interim Phase 2a Results for RT002 in Treating Plantar Fasciitis (Businesswire)
04.01.18	Revance Provides Update on Anticipated Clinical Milestones and Financial Outlook for 2018 (Businesswire)
02.01.18	KDMN And 10 Other Biotech Stocks You Should Watch This Month (RTTNews)
11.12.17	Revance Announces Closing of Public Offering of Common Stock (Businesswire)
07.12.17	Revance Announces Pricing of Public Offering of Common Stock (Businesswire)
06.12.17	RVNC's All Smiles, NVCR Catches Eyes, ACRS Waiting For Xmas Gift, KIDS Growing (RTTNews)
05.12.17	Revance Announces Proposed Public Offering of Common Stock (Businesswire)
05.12.17	Revance’s RT002 Meets Primary and All Secondary Endpoints, Achieves 6-Month Duration in Pivotal SAKURA Phase 3 Trials for Glabellar Lines (Businesswire)
30.11.17	TXMD Giving A 2nd Try, PLX On Watch, NAOV's Shield Against Suicide Disease (RTTNews)
29.11.17	Revance Plans Phase 3 Program for RT002 Injectable to Treat Cervical Dystonia (Businesswire)
20.11.17	Revance Announces Orphan Drug Designation of RT002 for the Treatment of Cervical Dystonia (Businesswire)
02.11.17	Revance Releases Third Quarter 2017 Results (Businesswire)
08.03.17	AXSM Looks To Busy Year Ahead, SUPN Makes Peace Again, ESPR Hits New High (RTTNews)
28.02.17	LJPC Climbs 76%, VTVT On Track, Eventful October Awaits ACRX, ATRS (RTTNews)
06.01.17	OTIC Hits Right Notes, GEMP To Report Data This Month, Busy Year Ahead For RVNC (RTTNews)
08.12.16	NWBO To Leave Nasdaq, Voyager Cruises Ahead, Watch Out For REGN (RTTNews)
15.07.16	Watch Out For BCLI, RARE's Phase 3 Trial Hits Goal, JUNO Opens Wallet (RTTNews)
14.06.16	RVNC Wrinkled, MRNS Jolted As Study Fails, BSTC Abuzz, FDA Snubs KMPH (RTTNews)
13.05.16	What Awaits These Phase 3 Trials - Guaranteed Success Or Costly Disappointment? (RTTNews)
03.03.16	OPXA Hands Out Pink Slips, KOOL Not So Hot, Time To Follow RVNC (RTTNews)
29.10.15	Revance Reports Positive 24-week Results For Injectable RT002; Stock Jumps (RTTNews)
30.09.15	Soothing Balm For Avita, NVAX Gets Booster Shot, RVNC On The Move (RTTNews)
29.09.15	ZSAN Abuzz With Activity, Titan Gets FDA Date, ESPR Down After Hours (RTTNews)
10.09.15	RVNC Works It Out, ONCE Awaits Data, AKBA, VTAE Make Big Moves, TTPH Doused (RTTNews)
07.08.15	AQXP Leads, ESPR To Meet With FDA, RPTP On Watch, CLSN Heating Up (RTTNews)
04.06.15	BLUE, CELG Fine Tune Deal, Lightlake Cruises Ahead, HALO Shines, CPXX On Track (RTTNews)
14.05.15	CORT For The Long Haul, RVNC Has No Reason To Frown, MSLI Swings To Profit (RTTNews)
09.01.15	FOLD Unfolds, No Pain, All Gain For NBIX, VSAR Picks Up Velocity, RVNC On Watch (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Revance Therapeutics Inc

Aktien Top/Flop

Meistgelesene Nachrichten